| Edgardo F Salvador Md Pc | |
|
3140 Sheridan Dr Ste 201 Amherst NY 14226-1911 | |
| (716) 832-2920 | |
| (716) 832-2956 |
| Full Name | Edgardo F Salvador Md Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 3140 Sheridan Dr, Amherst, New York |
| Authorized Official Name and Position | Edgardo F Salvador (OWNER) |
| Authorized Official Contact | 7168322920 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Edgardo F Salvador Md Pc 3140 Sheridan Dr Suite 201 Amherst NY 14226-1911 Ph: (716) 832-2920 | Edgardo F Salvador Md Pc 3140 Sheridan Dr Ste 201 Amherst NY 14226-1911 Ph: (716) 832-2920 |
| NPI Number | 1023214723 |
|---|---|
| Provider Enumeration Date | 06/21/2007 |
| Last Update Date | 05/07/2013 |
| Medicare PECOS PAC ID | 7618114158 |
|---|---|
| Medicare Enrollment ID | O20130501000058 |
News Archive
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature.
According to the Australasian College of Emergency Medicine (ACEM) any move which reduces the number of major trauma centres in New South Wales hospitals is long overdue.
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Medication that specifically targets cancer cells and delivers its active agent without harming healthy cells - this is what doctoral students of the Magicbullet network will be working on from mid-2015. Bielefeld University is coordinating the programme for the development of "gentle" cancer treatment.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023214723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 178811 (New York) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 178811 (New York) | Primary |
| Provider Name | Edgardo F Salvador |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1528080306 PECOS PAC ID: 9436109881 Enrollment ID: I20110412000390 |
News Archive
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature.
According to the Australasian College of Emergency Medicine (ACEM) any move which reduces the number of major trauma centres in New South Wales hospitals is long overdue.
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Medication that specifically targets cancer cells and delivers its active agent without harming healthy cells - this is what doctoral students of the Magicbullet network will be working on from mid-2015. Bielefeld University is coordinating the programme for the development of "gentle" cancer treatment.
› Verified 7 days ago
News Archive
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature.
According to the Australasian College of Emergency Medicine (ACEM) any move which reduces the number of major trauma centres in New South Wales hospitals is long overdue.
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Medication that specifically targets cancer cells and delivers its active agent without harming healthy cells - this is what doctoral students of the Magicbullet network will be working on from mid-2015. Bielefeld University is coordinating the programme for the development of "gentle" cancer treatment.
› Verified 7 days ago
Denardin Family Practice Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4949 Harlem Rd, Amherst, NY 14226 Phone: 716-839-1690 Fax: 716-839-6743 | |
Wny House Physician Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 60 Brynstone Ct, Amherst, NY 14228 Phone: 716-345-6960 | |
Thinfastmd Buffalo, Wisdom Medicine Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3380 Sheridan Dr, Suite 328, Amherst, NY 14226 Phone: 716-898-8335 | |
Joseph L. Maddi, Physician, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4225 Maple Rd, Amherst, NY 14226 Phone: 716-834-0281 Fax: 716-834-0222 | |
Stall Senior Medical Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4242 Ridge Lea Rd Ste 26, Amherst, NY 14226 Phone: 716-833-3237 Fax: 888-976-5853 | |
Gfd Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 John James Audubon Parkway, Amherst, NY 14228 Phone: 716-204-4500 Fax: 716-204-4501 |